Alva G - Search Results

1

Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine.

Potkin SG, Thyrum PT, Alva G, Carreon D, Yeh C, Kalali A, Arvanitis LA; Pharmacokinetic Study Group. Potkin SG, et al. Among authors: alva g. J Clin Psychopharmacol. 2002 Apr;22(2):174-82. doi: 10.1097/00004714-200204000-00011. J Clin Psychopharmacol. 2002. PMID: 11910263 Clinical Trial.

2

The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.

Potkin SG, Thyrum PT, Alva G, Bera R, Yeh C, Arvanitis LA. Potkin SG, et al. Among authors: alva g. J Clin Psychopharmacol. 2002 Apr;22(2):121-30. doi: 10.1097/00004714-200204000-00004. J Clin Psychopharmacol. 2002. PMID: 11910256 Clinical Trial.

3

Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.

Potkin SG, Thyrum PT, Bera R, Carreon D, Alva G, Kalali AH, Yeh C. Potkin SG, et al. Among authors: alva g. Clin Ther. 2002 Nov;24(11):1809-23. doi: 10.1016/s0149-2918(02)80081-9. Clin Ther. 2002. PMID: 12501876 Clinical Trial.

4

Brain metabolic effects of Neotrofin in patients with Alzheimer's disease.

Potkin SG, Alva G, Keator D, Carreon D, Fleming K, Fallon JH. Potkin SG, et al. Among authors: alva g. Brain Res. 2002 Sep 27;951(1):87-95. doi: 10.1016/s0006-8993(02)03140-2. Brain Res. 2002. PMID: 12231461 Clinical Trial.

5

Alzheimer disease and other dementias.

Alva G, Potkin SG. Alva G, et al. Clin Geriatr Med. 2003 Nov;19(4):763-76. doi: 10.1016/s0749-0690(03)00028-4. Clin Geriatr Med. 2003. PMID: 15024811 Review.

6

A PET study of the pathophysiology of negative symptoms in schizophrenia. Positron emission tomography.

Potkin SG, Alva G, Fleming K, Anand R, Keator D, Carreon D, Doo M, Jin Y, Wu JC, Fallon JH. Potkin SG, et al. Among authors: alva g. Am J Psychiatry. 2002 Feb;159(2):227-37. doi: 10.1176/appi.ajp.159.2.227. Am J Psychiatry. 2002. PMID: 11823264

7

Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia.

Jin Y, Potkin SG, Kemp AS, Huerta ST, Alva G, Thai TM, Carreon D, Bunney WE Jr. Jin Y, et al. Among authors: alva g. Schizophr Bull. 2006 Jul;32(3):556-61. doi: 10.1093/schbul/sbj020. Epub 2005 Oct 27. Schizophr Bull. 2006. PMID: 16254067 Free PMC article.

8

D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine.

Potkin SG, Basile VS, Jin Y, Masellis M, Badri F, Keator D, Wu JC, Alva G, Carreon DT, Bunney WE Jr, Fallon JH, Kennedy JL. Potkin SG, et al. Among authors: alva g. Mol Psychiatry. 2003 Jan;8(1):109-13. doi: 10.1038/sj.mp.4001191. Mol Psychiatry. 2003. PMID: 12556915 Clinical Trial.

9

Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease.

Potkin SG, Anand R, Fleming K, Alva G, Keator D, Carreon D, Messina J, Wu JC, Hartman R, Fallon JH. Potkin SG, et al. Among authors: alva g. Int J Neuropsychopharmacol. 2001 Sep;4(3):223-30. doi: 10.1017/S1461145701002528. Int J Neuropsychopharmacol. 2001. PMID: 11602028 Free article. Clinical Trial.

10

A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.

Basile VS, Ozdemir V, Masellis M, Walker ML, Meltzer HY, Lieberman JA, Potkin SG, Alva G, Kalow W, Macciardi FM, Kennedy JL. Basile VS, et al. Among authors: alva g. Mol Psychiatry. 2000 Jul;5(4):410-7. doi: 10.1038/sj.mp.4000736. Mol Psychiatry. 2000. PMID: 10889552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters